Bio-engineered Stent Market - Global Outlook and Forecast 2023-2028

Report ID: 1370303 | Published Date: Jan 2025 | No. of Page: 70 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story

This report contains market size and forecasts of Bio-engineered Stent in global, including the following market information:
Global Bio-engineered Stent Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Bio-engineered Stent Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Bio-engineered Stent companies in 2021 (%)
The global Bio-engineered Stent market was valued at 2797.7 million in 2021 and is projected to reach US$ 3855.9 million by 2028, at a CAGR of 4.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Metal-based Bio-engineered Stent Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Bio-engineered Stent include Medtronic, Boston Scientific, Abbott Laboratories, B. Braun Melsungen, BD, Terumo, MicroPort, Lepu Medical and Biotronik, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bio-engineered Stent manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bio-engineered Stent Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bio-engineered Stent Market Segment Percentages, by Type, 2021 (%)
Metal-based Bio-engineered Stent
Polymer-based Bio-engineered Stent
Global Bio-engineered Stent Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bio-engineered Stent Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Bio-engineered Stent Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bio-engineered Stent Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bio-engineered Stent revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Bio-engineered Stent revenues share in global market, 2021 (%)
Key companies Bio-engineered Stent sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Bio-engineered Stent sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Boston Scientific
Abbott Laboratories
B. Braun Melsungen
BD
Terumo
MicroPort
Lepu Medical
Biotronik
Biosensors
Stentys
Vascular Concepts

Frequently Asked Questions
Bio-engineered Stent Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Bio-engineered Stent Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Bio-engineered Stent Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Pemetrexed Market

Pemetrexed (brand name Alimta) is a chemotherapy drug manufactured and marketed by Eli Lilly and  ... Read More

DDI Market

This report contains market size and forecasts of DDI (DNS, DHCP, and IPAM) in Global, including  ... Read More